Anti-Cancer Drugs Journal Issues Research Articles in April 2023 Edition
March 20, 2023
March 20, 2023
LONDON, England, March 20 -- Anti-Cancer Drugs, a journal that says it reports clinical and experimental results related to anti-cancer drugs and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation, published research articles, including the following topics, in its April 2023 edition:
Review:
* Efficacy and safety of enfortumab vedotin in the treatment of advanced urothelial carc . . .
Review:
* Efficacy and safety of enfortumab vedotin in the treatment of advanced urothelial carc . . .